Literature DB >> 8248966

The J-curve phenomenon in stroke recurrence.

K Irie1, T Yamaguchi, K Minematsu, T Omae.   

Abstract

BACKGROUND AND
PURPOSE: The relation of poststroke blood pressure to stroke recurrence remains undetermined, and the optimal control of blood pressure has not been established. We performed the present study to resolve these issues.
METHODS: We analyzed 368 stroke patients with a history of hypertension (mean age, 62 years) who were admitted within 3 months after stroke onset and observed for 6 months or more. We determined stroke recurrence rate in relation to baseline (or initial) blood pressure, mean values of poststroke blood pressure, stroke subtypes, age, antihypertensive treatment, and other clinical features.
RESULTS: The recurrence rate had a J-curve relation to poststroke diastolic blood pressure but not to poststroke systolic blood pressure and baseline diastolic and systolic blood pressures. The stroke recurrence rate was 3.8% per patient-year in 94 patients who had a poststroke diastolic blood pressure of 80 to 84 mm Hg, significantly lower than the rates of 9.2% per patient-year (P < .05) and 11.4% per patient-year (P < .01) in those with a lower and higher poststroke diastolic blood pressure, respectively. The range of poststroke diastolic blood pressure accompanying the lowest stroke recurrence rate was higher in patients with atherothrombotic (85 to 89 mm Hg) than in those with lacunar infarction (80 to 84 mm Hg). Neither antihypertensive therapy nor patients' age affected this phenomenon.
CONCLUSIONS: The present study suggests that lower blood pressure does not always result in favorable effects on stroke recurrence. The effects of poststroke blood pressure and antihypertensive therapy on stroke recurrence may be complicated by the J-curve phenomenon.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248966     DOI: 10.1161/01.str.24.12.1844

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

Review 1.  Antihypertensive therapy in the prevention of stroke: what, when and for whom?

Authors:  M D Fotherby; B Panayiotou
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

2.  Cerebral Blood Flow before and after Treatment with Amlodipine in Elderly Patients with Lacunar Infarction.

Authors:  Toshio Imaizumi; Masahiko Chiba; Toshimi Honma; Junpei Yoshikawa; Jun Niwa
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

3.  Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group.

Authors:  A Rodgers; S MacMahon; G Gamble; J Slattery; P Sandercock; C Warlow
Journal:  BMJ       Date:  1996-07-20

Review 4.  Are cognitive function and blood pressure related?

Authors:  M Viitanen; Z Guo
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 5.  Lowering of blood pressure for recurrent stroke prevention.

Authors:  Andrea D Boan; Daniel T Lackland; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-07-01       Impact factor: 7.914

6.  Aetiopathogenesis and long-term outcome of isolated pontine infarcts.

Authors:  Konstantinos N Vemmos; Konstantinos Spengos; Georgios Tsivgoulis; Efstathios Manios; Vassilios Zis; Demetris Vassilopoulos
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

7.  Blood Pressure Management After Intracerebral Hemorrhage.

Authors:  Shoichiro Sato; Cheryl Carcel; Craig S Anderson
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

Review 8.  The J-Curve Phenomenon in Hypertension.

Authors:  Yuan-Yuan Kang; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2016-06-17

9.  Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients.

Authors:  G Tsivgoulis; K Spengos; N Zakopoulos; E Manios; K Xinos; D Vassilopoulos; K N Vemmos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 10.  Secondary prevention of stroke by blood pressure-lowering treatment.

Authors:  Hisatomi Arima; John Chalmers
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.